Orphalan is based at the Orphalan stand at the EEC2026 conference in Athens.
Public source
Publisher name
Public post
Discussions are well underway in Athens at #EEC2026. Managing paediatric epilepsy presents complex challenges, from the early recognition and timely diagnosis of infanti…
Company
Orphalan
At Orphalan we strive to develop rare disease treatments to improve patients lives.
- Industry
- Pharmaceutical Manufacturing
- Location
- Paris, FR
- Company size
- 51–200 employees
About Orphalan
Transforming Rare Disease Treatment At Orphalan we identify, develop, and provide access to innovative treatments for patients with rare diseases to make a positive and meaningful difference.
See moreLatest activity
Latest activity from Orphalan
2 signals
Discover more
Similar signals
Similar public activity from other companies.
Presence & Recognition
CHAPPER healthcare
CHAPPER healthcare is exhibiting at booth E50 in Hall A3 at the expopharm 2026 conference across all three days.
Presence & Recognition
Bluepharma
Bluepharma is participating in RNA Leaders APAC 2026 and the Asia Bio Partnering Forum 2026 in Singapore this week.
Presence & Recognition
Serva Health LLC
Serva Health LLC is attending the DPHARM 2026 conference in Boston in booth #102.
Presence & Recognition
World Orphan Drug Congress
World Orphan Drug Congress Europe 2026 will feature the Start-up Zone from 26 to 28 October in Amsterdam, allowing start-ups to showcase technology, pitch, connect with investors, and build visibility.
Presence & Recognition
Reacta Healthcare